First Time Loading...

Alphamab Oncology
HKEX:9966

Watchlist Manager
Alphamab Oncology Logo
Alphamab Oncology
HKEX:9966
Watchlist
Price: 5.3 HKD 3.92% Market Closed
Updated: May 19, 2024

Alphamab Oncology
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alphamab Oncology
Total Other Income Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Alphamab Oncology
HKEX:9966
Total Other Income
-¥984k
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Total Other Income
¥2.6B
CAGR 3-Years
N/A
CAGR 5-Years
440%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Total Other Income
-¥6.8m
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Total Other Income
-¥29.5m
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Total Other Income
¥249.8k
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Alphamab Oncology's Total Other Income?
Total Other Income
-984k CNY

Based on the financial report for Dec 31, 2023, Alphamab Oncology's Total Other Income amounts to -984k CNY.

What is Alphamab Oncology's Total Other Income growth rate?
Total Other Income CAGR 3Y
-24%

Over the last year, the Total Other Income growth was 12%. The average annual Total Other Income growth rates for Alphamab Oncology have been -24% over the past three years .